Clinical Trials Browser

Suspended × INDUSTRY × Solid Tumor × Clear all

NCT05938296 2025-11-19

oHSV2-PD-L1/CD3-BsAb Administered Via Intratumoral Injection

Phase 1 Suspended

Other solid neoplasm

Solid Tumor